These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2216297)
1. Clinical correlations with chemosensitivities measured in a simplified tritiated thymidine incorporation assay in patients with malignant effusion. Akiyoshi T; Wada T; Nakamura Y Oncology; 1990; 47(5):418-21. PubMed ID: 2216297 [TBL] [Abstract][Full Text] [Related]
2. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Sondak VK; Bertelsen CA; Tanigawa N; Hildebrand-Zanki SU; Morton DL; Korn EL; Kern DH Cancer Res; 1984 Apr; 44(4):1725-8. PubMed ID: 6704978 [TBL] [Abstract][Full Text] [Related]
3. A simplified tritiated thymidine incorporation assay for chemosensitivity testing of human tumors. Wada T; Akiyoshi T; Nakamura Y Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1421-4. PubMed ID: 3181266 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between BRCA1 mRNA expression in tumor cells from malignant effusions and chemosensitivity to cisplatin in patients with metastatic malignant effusions]. Qian XP; Liu BR; Jiang M; Hu J; Yu LX; Wang LF; Hu WJ; Zou ZY Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):457-60. PubMed ID: 21875488 [TBL] [Abstract][Full Text] [Related]
5. The effect of malignant effusions on methotrexate disposition. Li J; Gwilt P Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595 [TBL] [Abstract][Full Text] [Related]
6. Clinical application of the thymidine incorporation assay. Kern DH; Sondak VK; Morgan CR; Hildebrand-Zanki SU Ann Clin Lab Sci; 1987; 17(6):383-8. PubMed ID: 3688821 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay. Zirvi KA; Hill GJ; Hill HZ J Surg Oncol; 1986 Feb; 31(2):123-6. PubMed ID: 3713188 [TBL] [Abstract][Full Text] [Related]
8. [Prediction of the response to chemotherapy in acute leukemia through in-vitro incorporation of tritiated thymidine]. Zittoun R; Bouchard M; Facquet-Danis J; Percie-Du-Sert M; Bousser J Ann Med Interne (Paris); 1974 Nov; 125(11):811-6. PubMed ID: 4618066 [No Abstract] [Full Text] [Related]
9. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay. Friedman HM; Glaubiger DL Cancer Res; 1982 Nov; 42(11):4683-9. PubMed ID: 7127304 [TBL] [Abstract][Full Text] [Related]
10. Improvement of in vitro chemosensitivity assay for human solid tumors by application of a preculture using collagen matrix. Kitaoka A; Muraoka R; Tanigawa N Clin Cancer Res; 1997 Feb; 3(2):295-9. PubMed ID: 9815686 [TBL] [Abstract][Full Text] [Related]
11. Evolution and clinical application of a rapid chemosensitivity assay. Sondak VK; Bertelsen CA; Kern DH; Morton DL Cancer; 1985 Mar; 55(6):1367-71. PubMed ID: 3971305 [TBL] [Abstract][Full Text] [Related]
12. [Clinical application of chemosensitivity testing using radioactive precursors]. Ichihashi H Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1156-62. PubMed ID: 3729437 [TBL] [Abstract][Full Text] [Related]
13. In vitro chemotherapy sensitivity testing of human ovarian carcinoma: comparison of optical colony counting and [3H]thymidine incorporation assays. Tsushima K; Podratz KC; Stanhope CR; Lieber MM Gynecol Oncol; 1987 Oct; 28(2):170-80. PubMed ID: 3666575 [TBL] [Abstract][Full Text] [Related]
14. Correlation of cellular tritiated thymidine incorporation with soft agar clonogenicity in chemosensitivity testing of human neuroblastoma cells. Johnson GE; Glaubiger DL Cancer Treat Rep; 1983 Feb; 67(2):163-8. PubMed ID: 6825124 [No Abstract] [Full Text] [Related]
15. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters. Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270 [TBL] [Abstract][Full Text] [Related]
16. [3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer]. Belokhvostov AS Eksp Onkol; 1985; 7(6):50-3. PubMed ID: 4085399 [TBL] [Abstract][Full Text] [Related]
17. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Pillai V; Cibas ES; Dorfman DM Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119 [TBL] [Abstract][Full Text] [Related]
18. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306 [TBL] [Abstract][Full Text] [Related]
19. A simplified method for determination of tritiated thymidine incorporation into cells from tissue in soft agar culture. Akiyoshi T; Wada T; Nakamura Y; Tsuji H Jpn J Surg; 1986 May; 16(3):235-8. PubMed ID: 3735819 [TBL] [Abstract][Full Text] [Related]
20. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. Slipicevic A; Holth A; Hellesylt E; Tropé CG; Davidson B; Flørenes VA Gynecol Oncol; 2014 Oct; 135(1):118-24. PubMed ID: 25093290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]